Displaying items by tag: school of medicine

UAB scientist aims to inspire children from underrepresented backgrounds to pursue a career in science and help them understand that achieving their passions is possible.
$46 million awarded by NIH to UAB and partners allows researchers to continue following participants enrolled in the national Multicenter Osteoarthritis Study.
The newly introduced kidney function equation has value in predicting heart failure comparable to the old equation but may reduce racial disparities by improving access to heart failure therapy among Black heart failure patients.
Today the National Institutes of Health has announced that UAB’s own Jeanne Marrazzo, M.D., has been selected to succeed Anthony Fauci, M.D., as the next director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID) this fall. 
A first-of-its-kind endowment from art patrons Lydia Cheney and Jim Sokol will ensure the well-being of UAB’s Abroms-Engel Institute for the Visual Arts and contemporary art for years to come.
New research from UAB shows a possible link between poverty and a child’s possibility of having a relapse in their acute lymphoblastic leukemia.
Knowing the signs of this cancer can be lifesaving as sometimes the symptoms can mirror those of benign conditions.
Published results from two UAB studies found the duration of intermittent hypoxemia events and the presence and persistence of a patent ductus arteriosus after birth are two novel risk factors of BPD-PH in preterm infants.
The future has much potential as the REACH Up and Out program hopes to continue to make an impact on the lives of Black women in the Deep South.
Despite fewer drivers on the roads and fewer injuries per accident, fatal crashes in Alabama increased by 26 percent over the three years from 2020 through 2022.
Cure HHT has named the HHT Clinic at UAB Hospital a Center of Excellence. Only hospitals equipped with the proper personnel, expertise, commitment and resources to provide comprehensive evaluation, treatment and education to individuals with HHT and their families receive this designation.
To address the critical need for more emergency medical services in Birmingham and Alabama, UAB Hospital — with support from the State of Alabama — is creating 59 new exam rooms and more than 66,000 square feet of clinical space to meet service demand. 
UAB was involved in clinical trials that led to an accelerated approval of the drug lecanemab, commercially known as Leqembi, in January 2023. A UAB Alzheimer’s expert discusses the therapy and what full approval means for the AD field.
Page 8 of 166